Connection

Alessandro Armuzzi to Italy

This is a "connection" page, showing publications Alessandro Armuzzi has written about Italy.
Connection Strength

0.171
  1. Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre. United European Gastroenterol J. 2020 08; 8(7):775-781.
    View in: PubMed
    Score: 0.037
  2. Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts. Dig Liver Dis. 2017 Dec; 49(12):1298-1305.
    View in: PubMed
    Score: 0.030
  3. Psychological reaction to Covid-19 of Italian patients with IBD. BMC Psychol. 2021 Aug 06; 9(1):115.
    View in: PubMed
    Score: 0.010
  4. Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey. Inflamm Bowel Dis. 2020 10 23; 26(11):e134-e136.
    View in: PubMed
    Score: 0.009
  5. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. United European Gastroenterol J. 2020 12; 8(10):1228-1235.
    View in: PubMed
    Score: 0.009
  6. Italian IBD Patients Coping With Covid-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-care. Inflamm Bowel Dis. 2020 09 18; 26(10):e130-e131.
    View in: PubMed
    Score: 0.009
  7. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020 07; 69(7):1213-1217.
    View in: PubMed
    Score: 0.009
  8. Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study. Eur J Gastroenterol Hepatol. 2019 Nov; 31(11):1361-1369.
    View in: PubMed
    Score: 0.009
  9. Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease. Digestion. 2020; 101(4):433-440.
    View in: PubMed
    Score: 0.009
  10. Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study. Dig Liver Dis. 2019 04; 51(4):510-515.
    View in: PubMed
    Score: 0.008
  11. Unmet needs of Italian physicians managing patients with inflammatory bowel disease. Dig Liver Dis. 2019 02; 51(2):212-217.
    View in: PubMed
    Score: 0.008
  12. How clinicians and pathologists interact concerning inflammatory bowel disease in Italy: An IG-IBD survey. Dig Liver Dis. 2018 07; 50(7):734-736.
    View in: PubMed
    Score: 0.008
  13. Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease. Dig Liver Dis. 2017 Jun; 49(6):604-617.
    View in: PubMed
    Score: 0.007
  14. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Dig Liver Dis. 2017 04; 49(4):338-358.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.